Sep
1
2010
As Burger King holds talks with prospective buyers, including Brazilian-backed 3G Capital, it’s worth looking at how the buyout-backed fast food giant has performed since going public again in 2006. The answer: not well at all, especially compared with arch rival McDonald’s. Excluding the jump in Burger King’s stock price on Wednesday, thanks to reports [...]
no comments | tags: arch rival, Burger, food giant, Isn, Isn't, King's, Main Category, Post-I.P.O., price, Royal, Stock | posted in financial
Sep
1
2010
The chief executive of Genzyme, Henri A. Termeer, on Tuesday appeared to soften his tone about a possible sale, a day after his company rejected a $69-a-share offer from Sanofi-Aventis. In an interview with The Boston Globe, Mr. Termeer acknoweldged that Genzyme was now in play even as he reiterated that Sanofi’s price undervalued the [...]
no comments | tags: boston globe, Executive, Genzyme, Main Category, price, Right, sanofi aventis | posted in financial
Sep
1
2010
The chief executive of Genzyme, Henri A. Termeer, on Tuesday appeared to soften his tone about a possible sale, a day after his company rejected a $69-a-share offer from Sanofi-Aventis. In an interview with The Boston Globe, Mr. Termeer acknoweldged that Genzyme was now in play even as he reiterated that Sanofi’s price undervalued the [...]
no comments | tags: boston globe, Executive, Genzyme, Main Category, price, Right, sanofi aventis | posted in financial
Sep
1
2010
The chief executive of Genzyme, Henri A. Termeer, on Tuesday appeared to soften his tone about a possible sale, a day after his company rejected a $69-a-share offer from Sanofi-Aventis. In an interview with The Boston Globe, Mr. Termeer acknoweldged that Genzyme was now in play even as he reiterated that Sanofi’s price undervalued the [...]
no comments | tags: boston globe, Executive, Genzyme, Main Category, price, Right, sanofi aventis | posted in financial
Aug
26
2010
Former health care executive Rick Scott paid a price for his free-spending, no-holds-barred victory in Florida’s gubernatorial primary as he starts out the general election campaign with high personal negatives and running behind Democrat Alex Sink, according to a Public Policy Polling survey conducted Aug. 21-22. Sink, the state’s chief financial officer, leads Scott by [...]
no comments | tags: Behind, Divisive, Executive, Florida, florida governor race, Governor, health care executive, Main Category, Paying, price, Primary, Race:, Scott | posted in Politics
Aug
24
2010
Talks between the French pharmaceutical giant Sanofi-Aventis and the American biotech company Genzyme have hit a snag as the two sides try to agree on a threshhold price that would allow Sanofi to proceed with due diligence, The Wall Street Journal reports. Sanofi shareholders have signaled that they are reluctant to see their offer rise [...]
no comments | tags: Genzyme, Main Category, pharmaceutical giant, price, sanofi aventis, Sanofi-Genzyme, Stall, Talks | posted in financial